March 1, 2017 / 10:16 PM / 9 months ago

BRIEF-Nuvo Pharmaceuticals net income from cont ops $1.7 mln

March 1 (Reuters) - Nuvo Pharmaceuticals Inc:

* Nuvo Pharmaceuticals announces 2016 year-end and fourth quarter results

* Q4 revenue C$5.6 million versus C$7.7 million

* Nuvo Pharmaceuticals - total revenue for three months ended Dec 31, 2016 was $5.6 million compared to $7.7 million for three months ended December 31, 2015

* Nuvo Pharmaceuticals - net income from continuing operations $1.7 million for three months ended Dec 31, 2016 compared to $4.7 million for three months ended Dec 31, 2015

* Nuvo Pharmaceuticals Inc- company expects pennsaid 2% phase 3 trial to be completed and top-line results available in Q2 2017 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below